Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Osseis M, Nehmeh WA, Rassy N, et al. Surgery for T4 colorectal cancer in older patients: determinants of outcomes. J Pers Med. 2022;12(9):9. doi:10.3390/jpm12091534
   Web of Science ®Google Scholar
• Kim EJ, Baik GH. 만성위염, 장상피화생, 위암 환자의 위점막 상재균 변화의 차이에 대한 고찰 [Review on gastric mucosal microbiota profiling differences in patients with chronic gastritis, intestinal metaplasia, and gastric cancer]. Korean J Gastroenterol. 2014;64(6):390–393. Korean. doi:10.4166/kjg.2014.64.6.390
   PubMedGoogle Scholar
• Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 2014;20(30):10432–10439. doi:10.3748/wjg.v20.i30.10432
   PubMed Web of Science ®Google Scholar
• Liu X, Cai H, Wang Y. Prognostic significance of tumour markers in Chinese patients with gastric cancer. ANZ J Surg. 2014;84(6):448–453. doi:10.1111/j.1445-2197.2012.06287.x
   PubMed Web of Science ®Google Scholar
• Takayasu T, Shah M, Dono A, et al. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Sci Rep. 2020;10(1):14326. doi:10.1038/s41598-020-71161-0
   PubMed Web of Science ®Google Scholar
• Guo LY, Wu AH, Wang YX, Zhang LP, Chai H, Liang XF. Deep learning-based ovarian cancer subtypes identification using multi-omics data. BioData Min. 2020;13:10. doi:10.1186/s13040-020-00222-x
   PubMed Web of Science ®Google Scholar
• Rahat B, Ali T, Sapehia D, Mahajan A, Kaur J. Circulating cell-free nucleic acids as epigenetic biomarkers in precision medicine. Front Genet. 2020;11:844. doi:10.3389/fgene.2020.00844
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi:10.1261/rna.035667.112
   PubMed Web of Science ®Google Scholar
• Barrett SP, Salzman J. Circular RNAs: analysis, expression and potential functions. Development. 2016;143(11):1838–1847. doi:10.1242/dev.128074
   PubMed Web of Science ®Google Scholar
• Memczak S, Papavasileiou P, Peters O, Rajewsky N, Pfeffer S. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PLoS One. 2015;10(10):e0141214. doi:10.1371/journal.pone.0141214
   PubMed Web of Science ®Google Scholar
• Fan L, Li W, Jiang H. Circ_0000395 promoted CRC progression via elevating MYH9 expression by sequestering miR-432-5p. Biochem Genet. 2022;61(1):116–137. doi:10.1007/s10528-022-10245-0
   PubMed Web of Science ®Google Scholar
• Wang X, Chen M, Fang L. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3. Mol Ther Nucleic Acids. 2021;26:122–134. doi:10.1016/j.omtn.2021.07.003
   PubMedGoogle Scholar
• Bi J, Liu H, Cai Z, et al. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging. 2018;10(8):1964–1976. doi:10.18632/aging.101520
   PubMedGoogle Scholar
• Yang H, Li X, Meng Q, et al. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 2020;19(1):13. doi:10.1186/s12943-020-1139-3
   PubMed Web of Science ®Google Scholar
• Tian J, Xi X, Wang J, et al. CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer. Cancer Manag Res. 2019;11:5413–5423. doi:10.2147/CMAR.S199436
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Moreno CC, Mittal PK, Sullivan PS, et al. Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation. Clin Colorectal Cancer. 2016;15(1):67–73. doi:10.1016/j.clcc.2015.07.004
   PubMed Web of Science ®Google Scholar
• Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-The stable evidence. Nat Rev Clin Oncol. 2010;7(3):153–162. doi:10.1038/nrclinonc.2009.237
   PubMed Web of Science ®Google Scholar
• Oliart S, Martinez-Santos C, Moreno-Azcoita M, et al. Do MSI-L sporadic colorectal tumors develop through “mild mutator pathway”? Am J Clin Oncol. 2006;29(4):364–370. doi:10.1097/01.coc.0000221428.35366.cb
   PubMed Web of Science ®Google Scholar
• Adeleke S, Haslam A, Choy A, et al. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls. Per Med. 2022;19(4):277–286. doi:10.2217/pme-2021-0128
   PubMedGoogle Scholar
• Mathews NS, Masih D, Mittal R, et al. Microsatellite instability in young patients with mucinous colorectal cancers - characterization using molecular testing, immunohistochemistry, and histological features. Indian J Cancer. 2019;56(4):309–314. doi:10.4103/ijc.IJC_224_18
   PubMed Web of Science ®Google Scholar
• Pastore AL, Palleschi G, Silvestri L, et al. Serum and urine biomarkers for human renal cell carcinoma. Dis Markers. 2015;2015:251403. doi:10.1155/2015/251403
   PubMed Web of Science ®Google Scholar
• Boussios S, Ozturk MA, Moschetta M, et al. The developing story of predictive biomarkers in colorectal cancer. J Pers Med. 2019;9(1):1. doi:10.3390/jpm9010012
   PubMed Web of Science ®Google Scholar
• Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139–4147. doi:10.1002/cncr.32163
   PubMed Web of Science ®Google Scholar
• Omid-Shafaat R, Moayeri H, Rahimi K, et al. Serum Circ-FAF1/Circ-ELP3: a novel potential biomarker for breast cancer diagnosis. J Clin Lab Anal. 2021;35(11):e24008. doi:10.1002/jcla.24008
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C, Tan C, Liu X. Circular RNAs: a new frontier in the study of human diseases. J Med Genet. 2016;53(6):359–365. doi:10.1136/jmedgenet-2016-103758
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148. doi:10.1016/j.canlet.2015.06.003
   PubMed Web of Science ®Google Scholar
• Yu CY, Kuo HC. The emerging roles and functions of circular RNAs and their generation. J Biomed Sci. 2019;26(1):29. doi:10.1186/s12929-019-0523-z
   PubMedGoogle Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Chen LY, Wang L, Ren YX, et al. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1alpha translation. Mol Cancer. 2020;19(1):164. doi:10.1186/s12943-020-01272-9
   PubMed Web of Science ®Google Scholar
• Zhang YG, Yang HL, Long Y, Li WL. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG. 2016;123(13):2113–2118. doi:10.1111/1471-0528.13897
   PubMed Web of Science ®Google Scholar
• Bahn JH, Zhang Q, Li F, et al. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61(1):221–230. doi:10.1373/clinchem.2014.230433
   PubMed Web of Science ®Google Scholar
• Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol. 2017;14(8):992–999. doi:10.1080/15476286.2016.1220473
   PubMed Web of Science ®Google Scholar